logo
Can a Handful of Almonds Really Help Your Gut and Cholesterol?

Can a Handful of Almonds Really Help Your Gut and Cholesterol?

In the era of 'adaptogenic' everything and LED face masks promising to erase ten years overnight, the almond is as basic as it gets — humble, quietly smug, and apparently, newly anointed as a low-key hero for anyone with a less-than-perfect relationship with their cholesterol. No brand partnerships. Just a snack you've ignored in a trail mix, now positioned as a quiet powerhouse in metabolic health.
Recently, researchers at Oregon State University handed almonds their moment in the clinical spotlight, with information provided by the Almond Board of California (yes, a real board). Their subjects? Adults who have been asked to eat two ounces of almonds daily for twelve weeks. That's about 46 almonds a day, for anyone who enjoys precision.
After the trial, gut barrier function improved. Inflammation markers dropped. Total cholesterol and 'bad' LDL cholesterol took a dip. There was even a modest shrinking of the waistline — a result more reliable than any seasonal 'detox.' Let's not get carried away, though. No one floated out of the study looking like they'd spent a summer at a Swiss wellness clinic.
If 'metabolic syndrome' sounds familiar, that's because it's everywhere. One in three adults in the U.S. ticks the boxes for high blood sugar, high blood pressure, stubborn belly fat, and cholesterol numbers that get a 'let's talk' from your doctor. It's the reason for endless nutrition trends and why the new rules of keto and modern metabolic resets keep making headlines.
Here's the twist: almonds don't just help because they're 'healthy', they seemingly get at the root causes. Inflammation and oxidative stress are the true villains behind metabolic syndrome, quietly undermining the gut lining and orchestrating what's now called 'leaky gut syndrome.' That sets the stage for everything from cardiovascular disease to the kind of chronic, low-key fatigue that makes even a group text feel overwhelming.
Almonds, with their fiber, unsaturated fats, and antioxidant vitamin E, work as both gut fuel and cellular armor. As the Oregon State team put it: 'Almonds improved biomarkers of gut barrier function and decreased intestinal inflammation and LDL cholesterol in adults with metabolic syndrome.'
The gut story is about way more than digestion. When your intestinal lining is intact (think velvet rope at a members-only club), inflammation goes down everywhere: skin, joints, even mood. Research confirms that a healthy gut barrier helps regulate systemic inflammation, protecting everything from cardiovascular function to emotional well-being.
There's growing recognition that gut health is directly linked to skin clarity and beauty, and even mood — a gut-brain axis explored in depth in food as medicine for mental health.
For those building a gut-friendly routine, adding fermented foods can amplify the benefits of fiber-rich snacks like almonds, supporting a more diverse microbiome. Seasonal shifts? Even your allergies can be impacted, as a balanced microbiome helps moderate immune response. Sometimes the simplest seasonal reset is a focus on fiber and prebiotics as explained in this gut microbiome reset guide. Food is foundational, and almonds keep showing up on the 'worth it' list.
We've been told that eating an avocado a day might help with sleep, and now almonds are making a bid for pantry-staple status. Of course, a handful of nuts isn't a substitute for a complete lifestyle overhaul. But it's hard to beat the ROI.
Click here to learn more about The Almond Board of California
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise
Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

CNBC

time5 days ago

  • CNBC

Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its Entresto heart failure therapy. Sales of Kisqali, which treats metastatic breast cancer, surged 64% globally on a constant currency basis in the three months to June, the company said in its second-quarter sales report. That includes 100% growth in the U.S. It follows a 56% increase in Kisqali sales in the first quarter to March. Speaking on an earnings call, CEO Vas Narasimhan said Kisqali was the drug with the greatest scope for outperformance. Global breast cancer diagnoses and deaths are projected to increase by 2050, according to the World Health Organization's cancer agency, with 1 in 20 women worldwide expected to be diagnosed with breast cancer in their lifetime. That could translate to 3.2 million new cases and 1.1 million deaths a year worldwide by 2050 if current trends continue, the study found — significantly higher than 2022's 2.3 million new cases and 670,000-related deaths. Narasimhan also cited Novartis' "strong pipeline" of other drugs, including its Pluvicto prostate cancer treatment and Scemblix for chronic myeloid leukemia, which he said was also "on track to be a blockbuster." "We continue to drive strong performance on our ongoing launches for Kisqali, Pluvicto, and Scemblix, demonstrating the replacement power in our portfolio," he added in a statement accompanying the results. The comments come as Novartis seeks to shake its reliance on its top-selling Entreso heart failure drug, which faces U.S. patent expiry next year. Entresto brought in $7.8 billion in 2024, accounting for around 15% of the company's overall global sales. It said Thursday that it expects generic drug makers to begin producing copycat versions of the drug by mid-2025, although that timeline is "subject to ongoing IP [intellectual property] and regulatory litigation." On Wednesday, a U.S. federal judge rejected Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of the drug before the patent expires. Sales of Entresto rose 22% in the second quarter, in line with the prior three-month period. "Short-term it's an important product for us," outgoing chief financial officer Harry Kirsch said of Entresto Thursday. "We have IP that we're defending. Should we be successful in further defending our appeal, each month we'll have some nice significant upside," he added. Overall, Novartis' second-quarter net sales rose 11% on a constant currency basis to $14.05 billion, just shy of the $14.18 billion estimated by analysts in an LSEG poll. Quarterly adjusted core operating income, meanwhile, rose 21% to $5.93 billion, slightly above the $5.69 billion expected. Novartis said it now expects full-year core operating income to grow by "low teens," up from "low double-digit" previously, while it retained its forecast for sales growth in the high single digits. The company also announced an up to $10 billion share buyback, citing "confidence" in its mid- and long-term growth.

Biotech Breakthroughs in Anti-Aging: Decoding the Hallmarks of Aging and the Longevity Code
Biotech Breakthroughs in Anti-Aging: Decoding the Hallmarks of Aging and the Longevity Code

Associated Press

time6 days ago

  • Associated Press

Biotech Breakthroughs in Anti-Aging: Decoding the Hallmarks of Aging and the Longevity Code

The Hong Kong Society of Cosmetic Chemists (HKSCC) Invites Swiss Biotech Expert to unveil scientific truths behind aging HONG KONG SAR - Media OutReach Newswire - 16 July 2025 - From the popularity of anti-aging supplements and aesthetic treatments to Silicon Valley billionaires' pursuit of immortality, the global wave of anti-aging is gaining momentum, and Hong Kong is no exception. Questions like 'How to stay young?', 'Is NMN really effective?' and 'At what age should you start anti-aging care?' have become part of everyday conversation. While many are eager to delay the signs of aging, few truly understand the science behind it. Dr Fred Zülli (second from right), Founder and Business Development Director of Mibelle Biochemistry, Francis Kwan (second from left), President of HKSCC, Cirrus Chu (first from left), Sales Director of TPMC International Limited and Fanny Cheung (first from right), Director of NF Essential Limited attended the anti-aging seminar. From Hallmarks of Aging to Scientific Action: Effective Solutions Revealed To address this knowledge gap, Dr. Fred Zülli, Founder and Business Development Director of Swiss-based biotech company Mibelle Biochemistry, was specially invited to Hong Kong to co-host a seminar with the Hong Kong Society of Cosmetic Chemists. The seminar provided an in-depth look at the latest advancements in Swiss anti-aging research, starting with the 12 'Hallmarks of Aging' theory published in the journal Cell. Dr. Zülli explained how Swiss biotechnology is strategically targeting these biological mechanisms of aging and translating scientific breakthroughs into practical applications in skincare and aesthetic medicine, making age-defying solutions a scientific reality rather than a distant ideal. During the seminar, Dr. Zülli also revealed several truly effective, science-backed methods to combat aging. Next-Gen Skincare Science: Goji Stem Cell Extract with Dual Action Power for Repair Exosomes have rapidly emerged as one of the most promising technologies in the skincare industry. According to market data, the global exosome market was valued at over US$140 million in 2023 and is projected to expand at 28% CAGR by 2030. In the U.S., Google searches for 'exosomes' surged 17% in one year, evidence of rising consumer interest. Dr. Fred Zülli explains that exosomes are tiny vesicles that are released by cells into the extracellular space, rich in proteins, lipids, and nucleic acids. They can be derived from human, animals or plants cells, including plant stem cells, and reconstructed using liposome technology. These 'cellular messengers' play key roles in intercellular communication, immune modulation, and drug delivery. When used in skincare or microneedling treatments, they accelerate wound healing, enhance skin regeneration, and deliver deeper, faster, and safer results. Exosomes offer dual benefits: they strengthen the skin barrier while activating deeper cellular repair, improving overall skin quality, reducing fine lines, and restoring firmness for true inside-out anti-aging effects. Clinically Proven Plant Stem Cells Go Beyond Surface-Level Skincare Swiss researchers at Mibelle have developed the PhytoCellTec™ Exosomes technology, using natural Goji Stem Cell Extract to stimulate exosome production. This powerful natural ingredient demonstrates 'dual action', promoting keratinocyte differentiation and the expression of epidermal growth and antioxidant-related genes to reinforce the skin's outer barrier. Meanwhile, it reactivates mesenchymal stem cells (MSCs), boosting collagen synthesis and cellular vitality to enhance skin elasticity and density. Clinical studies show that a cream containing just 0.4% of Goji Stem Cell Extract significantly reduces fine lines and wrinkles after 56 days. Results can be seen in just 28 days with improved skin density and facial contour, and even firmness and lifting effects when applied to the breast area, showcasing its applications well beyond facial skincare. Exosomes in Daily Skincare and Medical Aesthetics With proven regenerative and wound-healing properties, exosomes are emerging as a viable alternative to stem cell therapies. As non-living biological elements, they are more stable and easier to handle. Exosome-based serums are particularly effective when used with microneedling, enabling deep skin repair and faster healing. Plant-derived exosomes have been shown to be bioavailable to mammalian cells and exhibit anti-inflammatory, antioxidant, anti-tumour, and skin-repairing benefits. Recent studies confirm their ability to combat skin aging, reinforcing their growing role in both cosmetic dermatology and everyday skincare. As this technology evolves, it promises a new era of personalized, science-backed beauty. Dual Stem Cell Formula: 'Swiss StemGlow Jelly' Nourishes Youthful Skin from Within; The brand 'LAB 91" Unveils Advanced Microneedle Skincare Powered by Deep Cellular Repair The Swiss StemGlow Jelly is an edible functional jelly formulated with dual stem cell active ingredients, Swiss apple stem cells and grape stem cells. These ingredients are renowned for enhancing cellular vitality, delivering antioxidant protection, and shielding the skin from UV damage. Meanwhile, LAB 91, a Swiss-made brand, specializes in microneedle skincare solutions. Its signature innovation, the Dual Plant Stem Cell Exosome Complex, combines rare Swiss apple stem cells with goji stem cells to deeply penetrate the skin and trigger cellular repair. Proven results include improved skin elasticity, lifted facial contours, and visibly diminished wrinkles. The brand offers a range of ampoule serums tailored to various skin concerns, including anti-aging, brightening and intensive repair. Together, the edible jelly and topical microneedle treatments deliver synergistic, cell-level rejuvenation from the inside out. Hashtag: #ESDLife The issuer is solely responsible for the content of this announcement. About ESDlife ESDlife, a joint venture of CK Hutchison (formerly Hutchison Whampoa) and Hewlett-Packard HK SAR, operates the award-winning website ( ) and establishes it as one of the most popular and trusted online lifestyle media in Hong Kong. The online platform of ESDlife is furnished with a wide range of lifestyles information under the categories of Wedding, Family and Health. In addition to the prominent No. 1 position of its Wedding Channel in Hong Kong, an e-commerce platform is provided to consumers by offering medical check-up ordering services. ESDlife also delivers integrated marketing and digital solutions to diversified corporate clients.

KA-EX, the world's first fast-acting cortisol stress reducer, is finally available in the U.S.
KA-EX, the world's first fast-acting cortisol stress reducer, is finally available in the U.S.

New York Post

time7 days ago

  • New York Post

KA-EX, the world's first fast-acting cortisol stress reducer, is finally available in the U.S.

Athletes and avid workout enthusiasts, rejoice: You can now get your hands on the world's first fast-acting cortisol stress reducer beverage! You'll never believe the story behind this citrus-flavored, highly effective drink: KA-EX, the dedicated sports nutrition brand, was originally launched in Switzerland as … wait for it … a hangover cure. This not-too-sweet natural beverage was widely embraced by the Swiss following long nights out, but almost as quickly, KA-EX was also embraced by professional and amateur athletes, due to its recovery benefits after a hard workout, sports game, competition or marathon. KA-EX reduces the 'stress hormone' cortisol within just 48 hours, while other benefits include reduction in muscle soreness, an increase in energy, longer REM sleep duration, reduction in mood disturbances, and protection against sport-induced premature skin aging. Something that can improve both sleep and skin – where do we sign up? Advertisement The brain behind KA-EX is CEO and founder Pedro Schmidt, a self-proclaimed 'nerd' who graduated from the pharmaceutical sciences program at the ETH Zurich – the same prestigious university that Albert Einstein attended. That's where, Schmidt tells the New York Post, 'I got interested in researching ways to improve hangover recovery – basically accelerate and also minimize the toxic effects of alcohol.' After all, most college students party too hard, and feeling good the next day is top of mind. CEO and Founder Pedro Schmidt Photo courtesy of KA-EX After Schmidt graduated, he started working at a high-paying pharmaceutical company in oncology and hepatology, but continued on his hangover-cure research before becoming a full-time entrepreneur. 'I was fascinated by the whole topic, and I got my first prototype, which I myself found very efficacious,' he explains. 'I gave it to my friends to test, and they basically pushed me to quit my job and bring it to market.' After a successful launch in pharmacies, KA-EX ('kater' is the German word for 'hangover,' and ex as in 'gone') quickly gained in popularity in Switzerland. Then something unexpected happened: 'More and more people started writing to us that KA-EX is an absolute game-changer for their post-workout recovery,' he recalls. 'They sleep better, feel more energized the next day, and see some significant progress in their [workout] performance.' Advertisement Eventually, professional athletes started approaching KA-EX, asking if it was safe to use. After three successful clinical trials, along with many athletes' stamp of approval, KA-EX repositioned itself as a dedicated sports nutrition brand. Schmidt unlocked the science on how to successfully reduce cortisol, which linked workout recovery and hangover recovery. 'In sports, cortisol management is an absolute game-changer, but it also plays a role in hangover recovery,' he says. 'So that is why I targeted cortisol management in the first place.' According to an independent study, the scientific staff of the Swiss national football team tested their players' cortisol levels and how KA-EX affected their recovery. After a game, an athlete's cortisol spikes, and it would take them 72 hours to get back to normal. After drinking KA-EX, however, their cortisol levels changed within 48 hours with a decrease of 36%. That percentage can make a huge difference in recovery! Here are some signs you have high cortisol levels: It's hard to make progress in your training, and you feel like you've plateaued You're not able to achieve maximal performance potential You have a hard time falling asleep You wake up in the middle of the night Advertisement 'While phosphatidylserine is the key ingredient directly involved in lowering cortisol, its fast-acting efficacy comes from a synergistic formula that supports multiple biological processes,' Schmidt explains. 'By promoting muscle repair and sleep through targeted amino acids, normalizing tissue pH levels, and reducing inflammation, the overall stress response is calmed more rapidly and effectively.' Photo courtesy of KA-EX Some of the biggest early supporters of KA-EX are members of professional sports teams, including world champions and Olympic winners across a variety of sports. Fabian Cancellara, a two-time Olympic gold medalist and CEO of Tudor Pro Cycling Team, states, 'As a holistic recovery product, KA-EX is the perfect complement to offer our rider the best possible conditions for top performance.' Zhou Guanyu, F1 driver for Alfa Romeo, says, 'Our team relies on KA-EX to be at our best in every circumstance.' Schmidt adds, 'Although KA-EX became popular through high-performing athletes, in Switzerland now it is one of the best-selling supplements on the market, sold in pharmacies, supermarkets, convenience stores and gyms. It is used by a very broad audience who are looking to improve their general well-being and day-to-day energy.' Advertisement This product comes in a patented bottle that keeps the powder separate from the pre-mixed liquid to preserve the stability of sensitive ingredients. The separation ensures that acidic and alkaline substances remain apart until activation. Once mixed, it should be consumed within an hour. After a successful launch last year at California locations of Equinox, KA-EX is currently available at Equinox Earthbar locations in New York and Los Angeles, Happier Grocery in New York City, GoPuff, BevMo, several F45 studios, Amazon, and The Feed. You can also find it online at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store